Compile Data Set for Download or QSAR
Report error Found 20 Enz. Inhib. hit(s) with all data for entry = 50042233
TargetIntegrin alpha-4/beta-1(Human)
Daiichi Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50157050([4-(1-{2-[3-Methoxy-4-(3-o-tolyl-ureido)-phenyl]-a...)
Affinity DataIC50: 1.40nMAssay Description:Inhibition of VLA-4 receptor expressed in CHO cellsMore data for this Ligand-Target Pair
In Depth
Date in BDB:
9/23/2013
Entry Details Article
PubMed
TargetIntegrin alpha-4/beta-1(Human)
Daiichi Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50157039([4-(1-{2-[3-Methoxy-4-(3-o-tolyl-ureido)-phenyl]-a...)
Affinity DataIC50: 1.60nMAssay Description:Inhibition of VLA-4 receptor expressed in CHO cellsMore data for this Ligand-Target Pair
In Depth
Date in BDB:
9/23/2013
Entry Details Article
PubMed
TargetIntegrin alpha-4/beta-1(Human)
Daiichi Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50157041([4-(1-{2-[3-Methoxy-4-(3-o-tolyl-ureido)-phenyl]-a...)
Affinity DataIC50: 1.60nMAssay Description:Inhibition of VLA-4 receptor expressed in CHO cellsMore data for this Ligand-Target Pair
In Depth
Date in BDB:
9/23/2013
Entry Details Article
PubMed
TargetIntegrin alpha-4/beta-1(Human)
Daiichi Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50157044([1-(1-{2-[4-(3-o-Tolyl-ureido)-phenyl]-acetyl}-pyr...)
Affinity DataIC50: 2.90nMAssay Description:Inhibition of VLA-4 receptor expressed in CHO cellsMore data for this Ligand-Target Pair
In Depth
Date in BDB:
9/23/2013
Entry Details Article
PubMed
TargetIntegrin alpha-4/beta-1(Human)
Daiichi Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50157046(4-[(1-{2-[4-(3-o-Tolyl-ureido)-phenyl]-acetyl}-pyr...)
Affinity DataIC50: 3.80nMAssay Description:Inhibition of VLA-4 receptor expressed in CHO cellsMore data for this Ligand-Target Pair
In Depth
Date in BDB:
9/23/2013
Entry Details Article
PubMed
TargetIntegrin alpha-4/beta-1(Human)
Daiichi Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50157048([1-(4-{2-[4-(3-o-Tolyl-ureido)-phenyl]-acetyl}-mor...)
Affinity DataIC50: 4.40nMAssay Description:Inhibition of VLA-4 receptor expressed in CHO cellsMore data for this Ligand-Target Pair
In Depth
Date in BDB:
9/23/2013
Entry Details Article
PubMed
TargetIntegrin alpha-4/beta-1(Human)
Daiichi Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50157034(5-(3-Methyl-butylcarbamoyl)-5-[(1-{2-[4-(3-o-tolyl...)
Affinity DataIC50: 4.70nMAssay Description:Inhibition of VLA-4 receptor expressed in CHO cellsMore data for this Ligand-Target Pair
In Depth
Date in BDB:
9/23/2013
Entry Details Article
PubMed
TargetIntegrin alpha-4/beta-1(Human)
Daiichi Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50157035(5-[(1-{2-[4-(3-o-Tolyl-ureido)-phenyl]-acetyl}-pyr...)
Affinity DataIC50: 7.10nMAssay Description:Inhibition of VLA-4 receptor expressed in CHO cellsMore data for this Ligand-Target Pair
In Depth
Date in BDB:
9/23/2013
Entry Details Article
PubMed
TargetIntegrin alpha-4/beta-1(Human)
Daiichi Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50157040(5-[(3-{2-[4-(3-o-Tolyl-ureido)-phenyl]-acetyl}-thi...)
Affinity DataIC50: 10nMAssay Description:Inhibition of VLA-4 receptor expressed in CHO cellsMore data for this Ligand-Target Pair
In Depth
Date in BDB:
9/23/2013
Entry Details Article
PubMed
TargetIntegrin alpha-4/beta-1(Human)
Daiichi Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50157051([4-(1-{2-[4-(3-o-Tolyl-ureido)-phenyl]-acetyl}-pyr...)
Affinity DataIC50: 13nMAssay Description:Inhibition of VLA-4 receptor expressed in CHO cellsMore data for this Ligand-Target Pair
In Depth
Date in BDB:
9/23/2013
Entry Details Article
PubMed
TargetIntegrin alpha-4/beta-1(Human)
Daiichi Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50157053([4-(1-{2-[4-(3-o-Tolyl-ureido)-phenyl]-acetyl}-pyr...)
Affinity DataIC50: 14nMAssay Description:Inhibition of VLA-4 receptor expressed in CHO cellsMore data for this Ligand-Target Pair
In Depth
Date in BDB:
9/23/2013
Entry Details Article
PubMed
TargetIntegrin alpha-4/beta-1(Human)
Daiichi Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50157043(5-[(1-{2-[4-(3-o-Tolyl-ureido)-phenyl]-acetyl}-2,5...)
Affinity DataIC50: 20nMAssay Description:Inhibition of VLA-4 receptor expressed in CHO cellsMore data for this Ligand-Target Pair
In Depth
Date in BDB:
9/23/2013
Entry Details Article
PubMed
TargetIntegrin alpha-4/beta-1(Human)
Daiichi Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50157047(5-[(4-{2-[4-(3-o-Tolyl-ureido)-phenyl]-acetyl}-mor...)
Affinity DataIC50: 26nMAssay Description:Inhibition of VLA-4 receptor expressed in CHO cellsMore data for this Ligand-Target Pair
In Depth
Date in BDB:
9/23/2013
Entry Details Article
PubMed
TargetIntegrin alpha-4/beta-1(Human)
Daiichi Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50157037(5-[(1-{2-[4-(3-o-Tolyl-ureido)-phenyl]-acetyl}-pip...)
Affinity DataIC50: 32nMAssay Description:Inhibition of VLA-4 receptor expressed in CHO cellsMore data for this Ligand-Target Pair
In Depth
Date in BDB:
9/23/2013
Entry Details Article
PubMed
TargetIntegrin alpha-4/beta-1(Human)
Daiichi Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50157038(4-[(1-{2-[4-(3-o-Tolyl-ureido)-phenyl]-acetyl}-pyr...)
Affinity DataIC50: 76nMAssay Description:Inhibition of VLA-4 receptor expressed in CHO cellsMore data for this Ligand-Target Pair
In Depth
Date in BDB:
9/23/2013
Entry Details Article
PubMed
TargetIntegrin alpha-4/beta-1(Human)
Daiichi Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50157036(3-[(1-{2-[4-(3-o-Tolyl-ureido)-phenyl]-acetyl}-pyr...)
Affinity DataIC50: 82nMAssay Description:Inhibition of VLA-4 receptor expressed in CHO cellsMore data for this Ligand-Target Pair
In Depth
Date in BDB:
9/23/2013
Entry Details Article
PubMed
TargetIntegrin alpha-4/beta-1(Human)
Daiichi Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50157049(4-{[(1-{2-[4-(3-o-Tolyl-ureido)-phenyl]-acetyl}-py...)
Affinity DataIC50: 121nMAssay Description:Inhibition of VLA-4 receptor expressed in CHO cellsMore data for this Ligand-Target Pair
In Depth
Date in BDB:
9/23/2013
Entry Details Article
PubMed
TargetIntegrin alpha-4/beta-1(Human)
Daiichi Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50157052(1-(1-{2-[4-(3-o-Tolyl-ureido)-phenyl]-acetyl}-pyrr...)
Affinity DataIC50: 148nMAssay Description:Inhibition of VLA-4 receptor expressed in CHO cellsMore data for this Ligand-Target Pair
In Depth
Date in BDB:
9/23/2013
Entry Details Article
PubMed
TargetIntegrin alpha-4/beta-1(Human)
Daiichi Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50157045(6-[(1-{2-[4-(3-o-Tolyl-ureido)-phenyl]-acetyl}-pyr...)
Affinity DataIC50: 295nMAssay Description:Inhibition of VLA-4 receptor expressed in CHO cellsMore data for this Ligand-Target Pair
In Depth
Date in BDB:
9/23/2013
Entry Details Article
PubMed
TargetIntegrin alpha-4/beta-1(Human)
Daiichi Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50157042([(1-{2-[4-(3-o-Tolyl-ureido)-phenyl]-acetyl}-pyrro...)
Affinity DataIC50: 1.00E+3nMAssay Description:Inhibition of VLA-4 receptor expressed in CHO cellsMore data for this Ligand-Target Pair
In Depth
Date in BDB:
9/23/2013
Entry Details Article
PubMed